(Hurley & Frier, 2025) For patients, this means the first question to ask of any provider offering peptide therapy isn't "do you offer peptides" but "how are you sourcing them and what is the current regulatory status of each compound you prescribe?" A provider still listing Category 2 compounds as standard menu offerings without discussing compounding compliance is telling you something important about their regulatory literacy
2007 Jun;49(6):794-801 Shepherd G, Velez LI
Tissue Repair and Regeneration BPC-157 has been studied for enhancing fibroblast proliferation, collagen synthesis, and re-epithelialization in wound models
Despite its popularity online, rigorous human trials are almost non-existent
Lets create a plan that works for you
Men receiving care at our Kelowna clinic undergo a personalized evaluation to ensure oral BPC-157 supports their recovery, performance, and overall wellness plan